These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 11371512)

  • 1. A mutation in the saposin A domain of the sphingolipid activator protein (prosaposin) gene results in a late-onset, chronic form of globoid cell leukodystrophy in the mouse.
    Matsuda J; Vanier MT; Saito Y; Tohyama J; Suzuki K; Suzuki K
    Hum Mol Genet; 2001 May; 10(11):1191-9. PubMed ID: 11371512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dramatic phenotypic improvement during pregnancy in a genetic leukodystrophy: estrogen appears to be a critical factor.
    Matsuda J; Vanier MT; Saito Y; Suzuki K; Suzuki K
    Hum Mol Genet; 2001 Nov; 10(23):2709-15. PubMed ID: 11726558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mutation in the saposin A coding region of the prosaposin gene in an infant presenting as Krabbe disease: first report of saposin A deficiency in humans.
    Spiegel R; Bach G; Sury V; Mengistu G; Meidan B; Shalev S; Shneor Y; Mandel H; Zeigler M
    Mol Genet Metab; 2005 Feb; 84(2):160-6. PubMed ID: 15773042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative clinico-pathological study of saposin-A-deficient (SAP-A-/-) and Twitcher mice.
    Yagi T; Matsuda J; Takikita S; Mohri I; Suzuki K; Suzuki K
    J Neuropathol Exp Neurol; 2004 Jul; 63(7):721-34. PubMed ID: 15290897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic ablation of Saposin-D in Krabbe disease eliminates psychosine accumulation but does not significantly improve demyelination.
    Watanabe T; Tsuboi K; Matsuda N; Ishizuka Y; Go S; Watanabe E; Ono A; Okamoto Y; Matsuda J
    J Neurochem; 2023 Aug; 166(4):720-746. PubMed ID: 37337846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rare Saposin A deficiency: Novel variant and psychosine analysis.
    Calderwood L; Wenger DA; Matern D; Dahmoush H; Watiker V; Lee C
    Mol Genet Metab; 2020 Feb; 129(2):161-164. PubMed ID: 31439510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Globoid cell leukodystrophy (Krabbe's disease): update.
    Suzuki K
    J Child Neurol; 2003 Sep; 18(9):595-603. PubMed ID: 14572137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seminolipid and its precursor/degradative product, galactosylalkylacylglycerol, in the testis of saposin A- and prosaposin-deficient mice.
    Tadano-Aritomi K; Matsuda J; Fujimoto H; Suzuki K; Ishizuka I
    J Lipid Res; 2003 Sep; 44(9):1737-43. PubMed ID: 12810822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzyme replacement therapy of a novel humanized mouse model of globoid cell leukodystrophy.
    Matthes F; Andersson C; Stein A; Eistrup C; Fogh J; Gieselmann V; Wenger DA; Matzner U
    Exp Neurol; 2015 Sep; 271():36-45. PubMed ID: 25956830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered Trafficking and Processing of GALC Mutants Correlates with Globoid Cell Leukodystrophy Severity.
    Shin D; Feltri ML; Wrabetz L
    J Neurosci; 2016 Feb; 36(6):1858-70. PubMed ID: 26865610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a mutation in a family with saposin B deficiency: a glycosylation site defect.
    Kretz KA; Carson GS; Morimoto S; Kishimoto Y; Fluharty AL; O'Brien JS
    Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2541-4. PubMed ID: 2320574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation in saposin D domain of sphingolipid activator protein gene causes urinary system defects and cerebellar Purkinje cell degeneration with accumulation of hydroxy fatty acid-containing ceramide in mouse.
    Matsuda J; Kido M; Tadano-Aritomi K; Ishizuka I; Tominaga K; Toida K; Takeda E; Suzuki K; Kuroda Y
    Hum Mol Genet; 2004 Nov; 13(21):2709-23. PubMed ID: 15345707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of a mouse with low galactocerebrosidase activity by gene targeting: a new model of globoid cell leukodystrophy (Krabbe disease).
    Luzi P; Rafi MA; Zaka M; Curtis M; Vanier MT; Wenger DA
    Mol Genet Metab; 2001 Jul; 73(3):211-23. PubMed ID: 11461188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AAV-mediated expression of galactocerebrosidase in brain results in attenuated symptoms and extended life span in murine models of globoid cell leukodystrophy.
    Rafi MA; Zhi Rao H; Passini MA; Curtis M; Vanier MT; Zaka M; Luzi P; Wolfe JH; Wenger DA
    Mol Ther; 2005 May; 11(5):734-44. PubMed ID: 15851012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Asn > Lys substitution in saposin B involving a conserved amino acidic residue and leading to the loss of the single N-glycosylation site in a patient with metachromatic leukodystrophy and normal arylsulphatase A activity.
    Regis S; Filocamo M; Corsolini F; Caroli F; Keulemans JL; van Diggelen OP; Gatti R
    Eur J Hum Genet; 1999; 7(2):125-30. PubMed ID: 10196694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophages Expressing GALC Improve Peripheral Krabbe Disease by a Mechanism Independent of Cross-Correction.
    Weinstock NI; Shin D; Dhimal N; Hong X; Irons EE; Silvestri NJ; Reed CB; Nguyen D; Sampson O; Cheng YC; Lau JTY; Bongarzone ER; Kofler J; Escolar ML; Gelb MH; Wrabetz L; Feltri ML
    Neuron; 2020 Jul; 107(1):65-81.e9. PubMed ID: 32375064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization and application of a disease-cell model for a neurodegenerative lysosomal disease.
    Ribbens JJ; Moser AB; Hubbard WC; Bongarzone ER; Maegawa GH
    Mol Genet Metab; 2014 Feb; 111(2):172-83. PubMed ID: 24094551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism-based combination treatment dramatically increases therapeutic efficacy in murine globoid cell leukodystrophy.
    Hawkins-Salsbury JA; Shea L; Jiang X; Hunter DA; Guzman AM; Reddy AS; Qin EY; Li Y; Gray SJ; Ory DS; Sands MS
    J Neurosci; 2015 Apr; 35(16):6495-505. PubMed ID: 25904800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Residual galactosylsphingosine (psychosine) beta-galactosidase activities and associated GALC mutations in late and very late onset Krabbe disease.
    Harzer K; Knoblich R; Rolfs A; Bauer P; Eggers J
    Clin Chim Acta; 2002 Mar; 317(1-2):77-84. PubMed ID: 11814461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late-onset Krabbe disease is predominant in Japan and its mutant precursor protein undergoes more effective processing than the infantile-onset form.
    Hossain MA; Otomo T; Saito S; Ohno K; Sakuraba H; Hamada Y; Ozono K; Sakai N
    Gene; 2014 Jan; 534(2):144-54. PubMed ID: 24252386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.